MAP
Madison Avenue Partners Portfolio holdings
AUM
$1.5B
This Quarter Return
+8.04%
1 Year Return
+26.66%
3 Year Return
+137.23%
5 Year Return
+278.64%
10 Year Return
–
AUM
$620M
AUM Growth
+$620M
(-12%)
Cap. Flow
-$124M
Cap. Flow
% of AUM
-20.03%
Top 10 Holdings %
Top 10 Hldgs %
92.19%
Holding
24
New
5
Increased
4
Reduced
4
Closed
6
Top Buys
| 1 |
John Wiley & Sons Class A
WLY
|
$52.1M |
| 2 |
Globus Medical
GMED
|
$37.7M |
| 3 |
Nelnet
NNI
|
$27.5M |
| 4 |
HomeStreet
HMST
|
$13.6M |
| 5 |
TSVT
2seventy bio
TSVT
|
$3.63M |
Top Sells
| 1 |
SharkNinja
SN
|
$117M |
| 2 |
Integra LifeSciences
IART
|
$45.4M |
| 3 |
G-III Apparel Group
GIII
|
$45M |
| 4 |
Vestis
VSTS
|
$28.5M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$24.5M |
Sector Composition
| 1 | Consumer Staples | 26.1% |
| 2 | Healthcare | 22.4% |
| 3 | Consumer Discretionary | 18.56% |
| 4 | Communication Services | 15.58% |
| 5 | Energy | 7.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Graham Holdings Company
GHC
$4.74B
| $162M | 26.1% | 210,717 +1,316 | +0.6% | +$1.01M |
|
|
2
SharkNinja
SN
$16.5B
| $113M | 18.16% | 1,807,237 -1,874,677 | -51% | -$117M |
|
3
Theravance Biopharma
TBPH
$699M
| $62.9M | 10.15% | 7,012,226 | – | – |
|
|
4
John Wiley & Sons Class A
WLY
$2.16B
| $52.1M | 8.41% | +1,366,771 | New | +$52.1M |
|
|
HES
5
DELISTED
Hess
HES
| $45.8M | 7.39% | 300,270 | – | – |
|
6
Stagwell
STGW
$1.46B
| $44.5M | 7.17% | 7,147,662 | – | – |
|
|
7
Globus Medical
GMED
$8.27B
| $37.7M | 6.09% | +703,276 | New | +$37.7M |
|
|
8
Nelnet
NNI
$4.65B
| $27.5M | 4.43% | +290,213 | New | +$27.5M |
|
|
9
HomeStreet
HMST
$262M
| $13.6M | 2.2% | +905,022 | New | +$13.6M |
|
|
TSVT
10
DELISTED
2seventy bio
TSVT
| $13M | 2.1% | 2,433,222 +678,434 | +39% | +$3.63M |
|
11
Ovid Therapeutics
OVID
$91M
| $11.1M | 1.8% | 3,648,509 | – | – |
|
|
ONL
12
Orion Office REIT
ONL
$167M
| $9.19M | 1.48% | 2,618,529 -371,036 | -12% | -$1.3M |
|
|
FSP
13
Franklin Street Properties
FSP
$172M
| $7.47M | 1.21% | 3,291,443 | – | – |
|
|
MACK
14
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $5.72M | 0.92% | 387,221 -165,864 | -30% | -$2.45M |
|
15
Gossamer Bio
GOSS
$562M
| $4.89M | 0.79% | 4,140,773 -913,699 | -18% | -$1.08M |
|
|
CEE
16
Central and Eastern Europe Fund
CEE
$105M
| $4.03M | 0.65% | 422,823 +148,866 | +54% | +$1.42M |
|
17
Indivior
INDV
$3.03B
| $3.49M | 0.56% | 162,895 +90,640 | +125% | +$1.94M |
|
18
Atmus Filtration Technologies
ATMU
$3.66B
| $2.47M | 0.4% | +76,732 | New | +$2.47M |
|
|
19
G-III Apparel Group
GIII
$1.17B
| – | – | -1,323,110 | Closed | -$45M |
|
|
20
Integra LifeSciences
IART
$1.18B
| – | – | -1,042,156 | Closed | -$45.4M |
|
21
Cartesian Therapeutics
RNAC
$261M
| – | – | -582,603 | Closed | -$402K |
|
|
22
Vestis
VSTS
$617M
| – | – | -1,346,980 | Closed | -$28.5M |
|
|
MRTX
23
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – | -417,427 | Closed | -$24.5M |
|
|
SFE
24
DELISTED
Safeguard Scientifics, Inc.
SFE
| – | – | -264,049 | Closed | -$207K |
|